About Petri Bio
Petri Bio is a company based in Los Angeles (United States) founded in 2019 by Joseph Schinaman. The company has 2 employees as of December 31, 2020.
- Headquarter Los Angeles, United States
- Employees 2 as on 31 Dec, 2020
- Founders Joseph Schinaman
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
-$49.26 K (USD)0as on Dec 30, 2020
-
EBITDA
Not available
-
Latest Funding Round
$1 M (USD), Grant
May 05, 2022
- Investors
-
Employee Count
2
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Petri Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Petri Bio
Investors in Petri Bio
Petri Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Petri Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Petri Bio
Investment portfolio details for Petri Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Petri Bio
Detailed financials for Petri Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Petri Bio Comparisons
Peer comparison for Petri Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Petri Bio
Detailed competitors of Petri Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Petri Bio
Complete news archive for Petri Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Petri Bio
Petri Bio was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Petri Bio is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
As of Dec 31, 2020, the latest employee count at Petri Bio is 2.
Petri Bio was founded in 2019 in Los Angeles, United States, with Joseph Schinaman serving as co-founder. Operations are centered on the production of drugs derived from microbes within the biotechnology sector. Manufacturing processes emphasize microbial technologies for pharmaceutical development. The company is headquartered in Los Angeles, and its online presence is maintained through the domain petribio.com. Focus remains on factual advancements in microbe-sourced therapeutics.
Petri Bio has 1 investor. Key investors include HHS.